
|Videos|December 10, 2014
Concerns Over Drug Interaction Alert Fatigue
Daniel C. Malone, RPh, PhD, FAMCP, defines drug interaction alert fatigue.
Advertisement
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, defines drug interaction alert fatigue.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
















































































































































































































